Although there is a debate on increased prevalence of high-grade tumors among 5-ARI-treated patients [79], a recent study showed that finasteride may attenuate tumor aggressiveness and invasion through MMP-2 and MMP-9 downregulation in prostate cancer cells [80]. This evidence concerns the gene MMP2 and prostate carcinoma.